Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 328 entries
View as:

S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01120249 Org: User:
Start: 04/01/11 End: 10/15/26 Due: 10/15/27

S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat

Phase: N/A Priority: Normal
NCT ID: NCT00017173 Org: User:
Start: 02/28/03 End: 07/31/11 Due: 07/31/12

Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03654768 Org: User:
Start: 10/24/18 End: 07/01/28 Due: 07/01/29

S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00058318 Org: User:
Start: 12/31/04 End: 11/30/08 Due: 11/30/09

S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00057928 Org: User:
Start: 04/30/03 End: 07/31/03 Due: 07/31/04

S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00058448 Org: User:
Start: 10/31/04 End: 11/30/05 Due: 11/30/06

S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00074295 Org: User:
Start: 03/31/04 End: 08/31/07 Due: 08/31/08

SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00002495 Org: User:
Start: 09/30/92 End: 04/30/14 Due: 04/30/15

S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib

Phase: N/A Priority: Normal
NCT ID: NCT02134912 Org: User:
Start: 08/31/14 End: 09/30/16 Due: 09/30/17

SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00900484 Org: User:
Start: 02/28/89 End: 10/31/11 Due: 10/31/12

S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium

Phase: N/A Priority: Normal
NCT ID: NCT00087295 Org: User:
Start: 06/30/04 End: 04/30/06 Due: 04/30/07

S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01360125 Org: User:
Start: 06/30/11 End: 12/31/15 Due: 12/31/16

S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02728804 Org: User:
Start: 06/22/16 End: 11/13/20 Due: 11/13/21

S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00107419 Org: User:
Start: 09/30/05 End: 08/31/09 Due: 08/31/10

S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia

Phase: N/A Priority: Normal
NCT ID: NCT00723658 Org: User:
Start: 09/30/08 End: - Due: -

S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00005089 Org: User:
Start: 04/30/00 End: 04/30/14 Due: 04/30/15

S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00053833 Org: User:
Start: 04/30/03 End: 07/31/04 Due: 07/31/05

S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003018 Org: User:
Start: 09/30/97 End: 01/31/07 Due: 01/31/08

S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003824 Org: User:
Start: 04/30/99 End: 01/31/07 Due: 01/31/08

S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000

Phase: N/A Priority: Normal
NCT ID: NCT00784225 Org: User:
Start: 07/31/04 End: 05/31/18 Due: 05/31/19

S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00945815 Org: User:
Start: 09/30/10 End: 08/31/17 Due: 08/31/18

S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx

Phase: N/A Priority: Normal
NCT ID: NCT00268372 Org: User:
Start: 12/31/05 End: 12/31/07 Due: 12/31/08

S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01598298 Org: User:
Start: 05/15/13 End: 12/20/18 Due: 12/20/19

S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004011 Org: User:
Start: 10/31/99 End: 11/30/12 Due: 11/30/13

Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT04647916 Org: User:
Start: 06/08/21 End: 12/31/28 Due: 12/31/29